![](https://investorshub.advfn.com/uicon/807674.png?cb=1670828933)
Thursday, June 27, 2024 12:27:18 PM
Foley thinks if he makes the injectors more profit, they will switch their patients to Daxi...WRONG...Injectors are reseller who are at the mercy of the aesthetic patient and kiss every patients butt hoping the patient will return to them and it costs an injector money (time) to switch a patient to Daxi. Cosmetic Injectors are all about the $$$$. Why does Allergan market directly to the aesthetic patient, everyday? Injectors are 100% aware that Allergan is squeezing their net profit out of Botox but "Change" is scary and Allergan keeps whispering in their ear, that "Botox will make the "practice" more profit." Allergan knows Daxi is much more profitable to the injector and is trying to confuse the injectors with "Practice" profit....Just so you know, typically, Toxin revenue is 50% to 60% of a practice's total annual revenue....what Allergan is telling the practice is 100% false. Foley waisted hundreds of millions and now WS see liabilities as greater than assets....TROUBLE...SP has dropped weekly.
FOLEY truly needs to understand medical marketing in a mature competitive market with a product which has 3 competitive advantages and is sold through a reseller as an annuity procedure. Offer the new product with 3 competitive advantages at the same price as the current market leaders. Establish market share and sell the company to a BIG Boy who will take it to the next level!
Educate the medical patient about the 3 competitive advantage and the $$$ they will save when using Daxi versus a 3 month toxin. Injectors who want to grow their Daxi patient base should be allowed to advertise their Daxi price on the the Daxi Injector Finder...love seeing injector pages listing...Botox $14 per unit, Daxi $7 per unit....now the patient will want to try the $7 per unit product which will give them the additional 3 benefits for the same price as Botox ( 2 to 1 units).Fast, Last and the Look! Patients will never go back to Botox!!! RVNC should be encouraging every unit pricing practice to advertise their Daxi this way!
Foley is clueless!
Recent RVNC News
- Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 06/14/2024 08:05:00 PM
- Revance to Participate in Upcoming Investor Conferences • Business Wire • 05/28/2024 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:33:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:08:10 PM
- Revance Reports First Quarter 2024 Financial Results, Provides Corporate Update • Business Wire • 05/09/2024 08:06:00 PM
- Revance Expands into the U.S. Therapeutics Market with the Launch of DAXXIFY® for the Treatment of Cervical Dystonia • Business Wire • 05/09/2024 08:05:00 PM
- Revance to Release First Quarter 2024 Financial Results on Thursday, May 9, 2024 • Business Wire • 05/02/2024 08:05:00 PM
- Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting • Business Wire • 04/12/2024 12:00:00 PM
- Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 03/27/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:33:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 10:08:05 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/05/2024 10:00:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 10:34:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 10:33:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 09:44:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 09:33:28 PM
- Revance Announces Pricing of $100.0 Million Public Offering of Common Stock • Business Wire • 03/04/2024 02:25:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/04/2024 11:39:11 AM
- Revance Announces Proposed Public Offering of Common Stock • Business Wire • 03/04/2024 11:37:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 09:36:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 09:07:18 PM
- Revance Reports Fourth Quarter and Full Year 2023 Financial Results, Provides Corporate Update • Business Wire • 02/28/2024 09:05:00 PM
- Revance to Release Fourth Quarter and Full Year 2023 Financial Results on Wednesday February 28, 2024 • Business Wire • 02/21/2024 01:01:00 PM
- Revance to Participate in Upcoming Investor Conferences • Business Wire • 02/21/2024 01:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 08:45:13 PM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM